Lenaxolan

Doxazosin mesilate, the active ingredient in Lenaxolan, is a alpha‑1 adrenergic blocker presented as an oral tablet for oral use. It is used to treat hypertension and benign prostatic hyperplasia in adult patients.

GNH USA supplies Lenaxolan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Doxazosin mesilate acts on the vascular smooth‑muscle and prostatic tissue to lower blood pressure and improve urinary flow.

- Hypertension: helps lower systolic and diastolic blood pressure in essential or secondary hypertension. - Benign prostatic hyperplasia: reduces prostate smooth‑muscle tone, easing urinary obstruction and frequency. - Lower urinary tract symptoms: improves urinary flow and reduces nocturia associated with BPH.

Doxazosin mesilate may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Dizziness or light‑headedness, especially after the first dose. - Headache. - Fatigue or tiredness. - Nasal congestion. - Swelling of the ankles or feet. - Nausea.

Serious or Rare Side Effects: - Severe hypotension or syncope. - Heart palpitations or arrhythmia. - Priapism (prolonged erection). - Liver function abnormalities. - Severe allergic reactions such as rash, itching, or swelling. - Persistent cough or bronchospasm.

Before initiating therapy with doxazosin mesilate, several safety considerations should be reviewed.

- Blood pressure monitoring: check baseline and periodic readings to avoid excessive hypotension. - Cardiovascular disease: use cautiously in patients with coronary artery disease or recent myocardial infarction. - Liver impairment: dose may need adjustment in moderate to severe hepatic dysfunction. - Concomitant antihypertensives: monitor for additive blood‑pressure lowering effects. - Pregnancy and lactation: safety not established; avoid unless clearly needed. - Store at ambient temperature: keep below 25 °C, retain in original container, protect from moisture and direct sunlight.

Doxazosin mesilate can interact with several medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Phosphodiesterase‑5 inhibitors (e.g., sildenafil): may cause profound hypotension. - Other alpha‑blockers (e.g., prazosin, terazosin): increase risk of severe blood‑pressure drop. - Strong CYP3A4 inhibitors (e.g., ketoconazole): can raise plasma concentrations.

Moderate Interactions (Monitor Closely):\n- Diuretics: may enhance orthostatic hypotension; monitor electrolytes. - Antihypertensive agents (beta‑blockers, ACE inhibitors): additive BP‑lowering effect. - NSAIDs: may blunt antihypertensive response. - Lithium: possible increase in lithium levels; monitor renal function.